Tranexamic Acid Tablet
|
Generic Name |
Tranexamic Acid |
|---|---|
|
Strength |
250 mg, 500 mg |
|
Form |
Tablet |
|
Packaging |
1x10 |
|
Therapeutic use |
Heavy Bleeding |
|
Manufacturing Period |
30 to 45 Days |
Available Composition of
| Name | Strength | Therapeutic use | View More |
|---|---|---|---|
| Tranexamic Acid Tablet | 250 mg, 500 mg | Heavy Bleeding | |
| Tranexamic Acid Cream | 5% w/w | Hyperpigmentation | |
| Tranexamic Acid and Mefenamic Acid Tablet | 500 mg + 250 mg | Heavy Bleeding, Pain killer | |
| Tranexamic Acid Injection | 250 mg, 500 mg | Heavy Bleeding |
Product Description For Tranexamic Acid Tablet
products details and uses
Tranexamic Acid Tablet Exporter India, Manufacturer and Global Supplier
Tranexamic Acid Tablet is a widely used antifibrinolytic medicine that helps prevent or reduce excessive bleeding caused by conditions such as heavy menstrual periods, surgery, dental extraction, or trauma. As a reputed Tranexamic Acid Tablet Exporter India, we specialize in manufacturing and supplying premium-grade formulations that meet stringent international quality standards. Our products are developed in WHO-GMP and ISO-certified facilities, ensuring safety, efficacy, and compliance with pharmacopeia specifications (IP/USP/BP/EP).
Being a trusted Tranexamic Acid Tablet Exporter India, we serve global markets across Asia, Africa, the Middle East, and Latin America, providing superior pharmaceutical solutions with reliable export documentation and on-time delivery. Tranexamic Acid is a synthetic derivative of lysine that works by inhibiting the breakdown of fibrin clots, effectively controlling bleeding in various medical conditions.
Uses of Tranexamic Acid Tablet
-
Reduces heavy menstrual bleeding (menorrhagia) effectively
-
Prevents bleeding during dental or surgical procedures
-
Controls nosebleeds (epistaxis) and internal bleeding
-
Used in post-operative hemorrhage to minimize blood loss
-
Manages hereditary angioedema by reducing swelling episodes
-
Helps prevent excessive bleeding after trauma or childbirth
As a leading Tranexamic Acid Tablet Exporter India, we ensure that our products are clinically effective, well-tested, and manufactured under strict quality control conditions.
Precautions
-
Use only under medical supervision and as prescribed by your doctor
-
Avoid if you have a history of blood clots (thrombosis) or kidney disease
-
Drink plenty of water to prevent kidney stone formation
-
Inform your doctor if you are pregnant or breastfeeding before use
-
Do not use with oral contraceptives without medical advice, as it may increase clot risk
-
Regular monitoring of renal function may be required in long-term therapy
-
Avoid alcohol and maintain hydration during treatment
As a responsible Tranexamic Acid Tablet Exporter India, we emphasize patient safety and compliance with all international pharmacovigilance norms.
Possible Side Effects
Tranexamic Acid Tablets are generally well-tolerated, but some users may experience mild side effects such as:
-
Nausea or vomiting
-
Diarrhea or stomach discomfort
-
Headache or dizziness
-
Muscle pain or fatigue
-
Vision changes or blurred vision (rare)
-
Allergic rash or itching in sensitive individuals
If any severe side effects or symptoms of blood clots (pain, swelling, shortness of breath) occur, seek immediate medical attention. As a trusted Tranexamic Acid Tablet Exporter India, we ensure that all products are tested for safety, stability, and purity before export.
Why Choose Us as Your Tranexamic Acid Tablet Exporter India?
-
WHO-GMP, ISO, and FDA-approved manufacturing units
-
Products comply with IP/BP/USP standards
-
Competitive pricing with consistent global supply
-
Customizable formulations, packaging, and branding support
-
Comprehensive export documentation (COA, MSDS, stability data)
-
Dedicated quality assurance and logistics team for timely delivery
Global Distribution Network
With a strong logistics and compliance framework, we successfully export to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.
